{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T23:14:51Z","timestamp":1775690091004,"version":"3.50.1"},"reference-count":43,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"unspecified","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","award":["BRC-1215-20005"],"award-info":[{"award-number":["BRC-1215-20005"]}],"id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","award":["RP-2017-08-ST2-006"],"award-info":[{"award-number":["RP-2017-08-ST2-006"]}],"id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","award":["110049\/Z\/15\/A"],"award-info":[{"award-number":["110049\/Z\/15\/A"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","award":["110049\/Z\/15\/Z"],"award-info":[{"award-number":["110049\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,2,15]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>It is unclear how pharmacological and non-pharmacological interventions compare with each other in terms of efficacy and tolerability for core symptoms and additional problems in adults with attention-deficit\/hyperactivity disorder (ADHD). We aim to conduct the first network meta-analysis (NMA) comparing pharmacological and non-pharmacological interventions (or their combinations) in adults with ADHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for NMAs. We will search a broad set of electronic databases\/registries and contact drug companies and experts in the field to retrieve published and unpublished randomised controlled trials (RCTs) (parallel or cross-over) of medications (either licensed or unlicensed) and any non-pharmacological intervention in adults (\u226518 years) with ADHD. Primary outcomes will be: (1) change in severity of ADHD core symptoms, and (2) acceptability (all-cause discontinuation). Secondary outcomes will include tolerability (drop-out due to side effects) and change in the severity of emotional dysregulation, executive dysfunctions and quality of life. The risk of bias in each individual RCT included in the NMA will be assessed using the Cochrane Risk of Bias tool-version 2. We will evaluate the transitivity assumption comparing the distribution of possible effect modifiers across treatment comparisons. We will perform Bayesian NMA for each outcome with random-effects model in OpenBUGS. Pooled estimates of NMA will be obtained using the Markov Chains Monte Carlo method. We will judge the credibility in the evidence derived from the NMA using the CINeMA tool (which includes assessment of publication bias). We will conduct a series of sensitivity analyses to assess the robustness of the findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>As this is the protocol for an aggregate-data level NMA, ethical approval will not be required. Results will be disseminated at national\/international conferences and in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42021265576.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-058102","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T11:43:11Z","timestamp":1646998991000},"page":"e058102","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacological and non-pharmacological interventions for adults with ADHD: protocol for a systematic review and network meta-analysis"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5877-8075","authenticated-orcid":false,"given":"Samuele","family":"Cortese","sequence":"first","affiliation":[{"name":"School of Psychology, Centre for Innovation in Mental Health (CIMH), Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK"},{"name":"Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK"},{"name":"Solent NHS Trust, Southampton, UK"},{"name":"Hassenfeld Children\u2019s Hospital at NYU Langone, New York University Child Study Center, New York City, New York, USA"},{"name":"Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Del Giovane","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio, Modena, Italy"},{"name":"Institute of Primary Health Care, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Chamberlain","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, University of Southampton, Southampton, UK"},{"name":"Southern Health NHS Foundation Trust, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Philipsen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Psychology, Reykjavik University, Reykjavik, Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bilbow","sequence":"additional","affiliation":[{"name":"Attention Deficit Disorder Information and Support Service, London, UK"},{"name":"ADHD-Europe, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5179-8321","authenticated-orcid":false,"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Oxford, UK"},{"name":"Oxford Health NHS Foundation Trust, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"2025121512322985000_12.3.e058102.1","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2020-300158"},{"key":"2025121512322985000_12.3.e058102.2","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2021-300277"},{"key":"2025121512322985000_12.3.e058102.3","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2020-300231"},{"key":"2025121512322985000_12.3.e058102.4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S2215-0366(16)30190-0","article-title":"Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies","volume":"3","author":"Sibley","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"2025121512322985000_12.3.e058102.5","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.11.04009","article-title":"The prevalence of adult attention-deficit hyperactivity disorder: a global systematic review and meta-analysis","volume":"11","author":"Song","year":"2021","journal-title":"J Glob Health"},{"key":"2025121512322985000_12.3.e058102.6","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1038\/nrdp.2015.20","article-title":"Attention-deficit\/hyperactivity disorder","volume":"1","author":"Faraone","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2025121512322985000_12.3.e058102.7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eurpsy.2019.06.011","article-title":"The economic burden of adult attention deficit hyperactivity disorder: a sibling comparison cost analysis","volume":"61","author":"Daley","year":"2019","journal-title":"Eur Psychiatry"},{"key":"2025121512322985000_12.3.e058102.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1917069"},{"key":"2025121512322985000_12.3.e058102.9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"2025121512322985000_12.3.e058102.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2017.08.010"},{"key":"2025121512322985000_12.3.e058102.11","unstructured":"National Institute for Health and Care Excellence . Attention deficit hyperactivity disorder: diagnosis and management, 2018. Available: https:\/\/www.nice.org.uk\/guidance\/ng87"},{"key":"2025121512322985000_12.3.e058102.12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jamapsychiatry.2015.2146","article-title":"Effects of group psychotherapy, individual counseling, methylphenidate, and placebo in the treatment of adult attention-deficit\/hyperactivity disorder: a randomized clinical trial","volume":"72","author":"Philipsen","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"2025121512322985000_12.3.e058102.13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1017\/S0033291720000069","article-title":"Non-pharmacological interventions for adult ADHD: a systematic review","volume":"50","author":"Nimmo-Smith","year":"2020","journal-title":"Psychol Med"},{"key":"2025121512322985000_12.3.e058102.14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.invent.2014.11.004","article-title":"Living SMART \u2014 a randomized controlled trial of a guided online course teaching adults with ADHD or sub-clinical ADHD to use smartphones to structure their everyday life","volume":"2","author":"Mo\u00ebll","year":"2015","journal-title":"Internet Interv"},{"key":"2025121512322985000_12.3.e058102.15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/1087054714539998","article-title":"Internet-based cognitive behavioral therapy for adults with ADHD in outpatient psychiatric care","volume":"21","author":"Pettersson","year":"2017","journal-title":"J Atten Disord"},{"key":"2025121512322985000_12.3.e058102.16","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2021-300346"},{"key":"2025121512322985000_12.3.e058102.17","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"2025121512322985000_12.3.e058102.18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S2215-0366(20)30137-1","article-title":"Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis","volume":"7","author":"Zhou","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"2025121512322985000_12.3.e058102.19","unstructured":"National Institute for Health Research . Available: https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=265576"},{"key":"2025121512322985000_12.3.e058102.20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S2215-0366(19)30096-3","article-title":"Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder-outcome measures beyond symptom control and clinical trials","volume":"6","author":"Wong","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"2025121512322985000_12.3.e058102.21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40263-021-00825-w","article-title":"Viloxazine in the management of CNS disorders: a historical overview and current status","volume":"35","author":"Findling","year":"2021","journal-title":"CNS Drugs"},{"key":"2025121512322985000_12.3.e058102.22","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1017\/S0033291716000350","article-title":"Effects of methylphenidate on executive functioning in attention-deficit\/hyperactivity disorder across the lifespan: a meta-regression analysis","volume":"46","author":"Tamminga","year":"2016","journal-title":"Psychol Med"},{"key":"2025121512322985000_12.3.e058102.23","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r13015","article-title":"Effect of continuing and discontinuing medications on quality of life after symptomatic remission in attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"81","author":"Tsujii","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"2025121512322985000_12.3.e058102.24","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0368-4","article-title":"Data extraction for complex meta-analysis (DECiMAL) guide","volume":"5","author":"Pedder","year":"2016","journal-title":"Syst Rev"},{"key":"2025121512322985000_12.3.e058102.25","unstructured":"Higgins JT , Chandler J , Cumpston M . Cochrane Handbook for systematic reviews of interventions version 6.2 (updated February 2021), 2021. Cochrane. Available: www.training.cochrane.org\/handbook"},{"key":"2025121512322985000_12.3.e058102.26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2215-0366(20)30566-6","article-title":"Comparative efficacy and acceptability of psychological interventions for the treatment of adult outpatients with anorexia nervosa: a systematic review and network meta-analysis","volume":"8","author":"Solmi","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"2025121512322985000_12.3.e058102.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7066.1200"},{"key":"2025121512322985000_12.3.e058102.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.06.006"},{"key":"2025121512322985000_12.3.e058102.29","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-2-201307160-00008"},{"key":"2025121512322985000_12.3.e058102.30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"key":"2025121512322985000_12.3.e058102.31","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3680"},{"key":"2025121512322985000_12.3.e058102.32","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1201"},{"key":"2025121512322985000_12.3.e058102.33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076654"},{"key":"2025121512322985000_12.3.e058102.34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025121512322985000_12.3.e058102.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.08.012"},{"key":"2025121512322985000_12.3.e058102.36","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys041"},{"key":"2025121512322985000_12.3.e058102.37","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys222"},{"key":"2025121512322985000_12.3.e058102.38","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1044"},{"key":"2025121512322985000_12.3.e058102.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"2025121512322985000_12.3.e058102.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.010"},{"key":"2025121512322985000_12.3.e058102.41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099682"},{"key":"2025121512322985000_12.3.e058102.42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003082"},{"key":"2025121512322985000_12.3.e058102.43","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-021-02166-3","article-title":"ROB-MEN: a tool to assess risk of bias due to missing evidence in network meta-analysis","volume":"19","author":"Chiocchia","year":"2021","journal-title":"BMC Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-058102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:32:43Z","timestamp":1765830763000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-058102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,11]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/bmjopen-2021-058102"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-058102","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}